131 related articles for article (PubMed ID: 30565727)
1. A full Bayesian model to handle structural ones and missingness in economic evaluations from individual-level data.
Gabrio A; Mason AJ; Baio G
Stat Med; 2019 Apr; 38(8):1399-1420. PubMed ID: 30565727
[TBL] [Abstract][Full Text] [Related]
2. A Bayesian Framework for Patient-Level Partitioned Survival Cost-Utility Analysis.
Gabrio A
Med Decis Making; 2021 Nov; 41(8):1033-1048. PubMed ID: 34009065
[TBL] [Abstract][Full Text] [Related]
3. Flexible Bayesian longitudinal models for cost-effectiveness analyses with informative missing data.
Mason AJ; Gomes M; Carpenter J; Grieve R
Health Econ; 2021 Dec; 30(12):3138-3158. PubMed ID: 34562295
[TBL] [Abstract][Full Text] [Related]
4. Joint Longitudinal Models for Dealing With Missing at Random Data in Trial-Based Economic Evaluations.
Gabrio A; Hunter R; Mason AJ; Baio G
Value Health; 2021 May; 24(5):699-706. PubMed ID: 33933239
[TBL] [Abstract][Full Text] [Related]
5. Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section.
Cooper NJ; Sutton AJ; Abrams KR
Stat Methods Med Res; 2002 Dec; 11(6):491-512. PubMed ID: 12516986
[TBL] [Abstract][Full Text] [Related]
6. A Bayesian parametric approach to handle missing longitudinal outcome data in trial-based health economic evaluations.
Gabrio A; Daniels MJ; Baio G
J R Stat Soc Ser A Stat Soc; 2020 Feb; 183(2):607-629. PubMed ID: 34385761
[TBL] [Abstract][Full Text] [Related]
7. A Bayesian framework for health economic evaluation in studies with missing data.
Mason AJ; Gomes M; Grieve R; Carpenter JR
Health Econ; 2018 Nov; 27(11):1670-1683. PubMed ID: 29969834
[TBL] [Abstract][Full Text] [Related]
8. Bayesian models for cost-effectiveness analysis in the presence of structural zero costs.
Baio G
Stat Med; 2014 May; 33(11):1900-13. PubMed ID: 24343868
[TBL] [Abstract][Full Text] [Related]
9. Methods for Handling Unobserved Covariates in a Bayesian Update of a Cost-effectiveness Model.
Thorpe B; Carroll O; Sharples L
Med Decis Making; 2018 Feb; 38(2):150-162. PubMed ID: 29202637
[TBL] [Abstract][Full Text] [Related]
10. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
[TBL] [Abstract][Full Text] [Related]
11. A Bayesian missing data framework for generalized multiple outcome mixed treatment comparisons.
Hong H; Chu H; Zhang J; Carlin BP
Res Synth Methods; 2016 Mar; 7(1):6-22. PubMed ID: 26536149
[TBL] [Abstract][Full Text] [Related]
12. An illustration of the modelling of cost and efficacy data from a clinical trial.
Hahn S; Whitehead A
Stat Med; 2003 Mar; 22(6):1009-24. PubMed ID: 12627415
[TBL] [Abstract][Full Text] [Related]
13. A dynamic Bayesian Markov model for health economic evaluations of interventions in infectious disease.
Haeussler K; den Hout AV; Baio G
BMC Med Res Methodol; 2018 Aug; 18(1):82. PubMed ID: 30068316
[TBL] [Abstract][Full Text] [Related]
14. Issues for statisticians in pharmaco-economic evaluations.
Grieve AP
Stat Med; 1998 Aug 15-30; 17(15-16):1715-23; discussion 1741-3. PubMed ID: 9749442
[TBL] [Abstract][Full Text] [Related]
15. [Bayesian approach for the cost-effectiveness evaluation of healthcare technologies].
Berchialla P; Gregori D; Brunello F; Veltri A; Petrinco M; Pagano E
Epidemiol Prev; 2009; 33(3):123-8. PubMed ID: 19776461
[TBL] [Abstract][Full Text] [Related]
16. Economic evaluations of clinical pharmacy services: 2006-2010.
Touchette DR; Doloresco F; Suda KJ; Perez A; Turner S; Jalundhwala Y; Tangonan MC; Hoffman JM
Pharmacotherapy; 2014 Aug; 34(8):771-93. PubMed ID: 24644086
[TBL] [Abstract][Full Text] [Related]
17. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
[TBL] [Abstract][Full Text] [Related]
18. An empirical comparison of Bayesian modelling strategies for missing binary outcome data in network meta-analysis.
Spineli LM
BMC Med Res Methodol; 2019 Apr; 19(1):86. PubMed ID: 31018836
[TBL] [Abstract][Full Text] [Related]
19. Continuous(ly) missing outcome data in network meta-analysis: A one-stage pattern-mixture model approach.
Spineli LM; Kalyvas C; Papadimitropoulou K
Stat Methods Med Res; 2021 Apr; 30(4):958-975. PubMed ID: 33406990
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
